Synergic highly effective photothermal-chemotherapy with platinum prodrug linked melanin-like nanoparticles
Source abstract
Abstract
Cisplatin is widely used in cancer treatment, but the application is limited due to toxicities and its acquired resistance. In this study, we delivered cisplatin to prostate cancer cells by linking the platinum prodrug Pt(IV) to melanin-like nanoparticles (MeNPs), a promising photothermal therapeutic agent with excellent biocompatibility. As expected, the Pt(IV)-MeNPs exhibited brilliant synergic photothermal-chemotherapy upon near-infrared reflection exposure. Compared with free cisplatin, Pt(IV)-MeNPs displayed highly effective antitumour activity both in vitro and in vivo.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Funding
National Natural Science Foundation of China · Project of Invigorating Health Care through Science, Technology and Education Jiangsu Provincial Key Medical Discipline, the Social Development Project of Nanjing
References (32)
Show source-provided references
1. 10.1038/nrc216710.1038/nrc2167 ↗
2. 10.2174/092986705463762610.2174/0929867054637626 ↗
3. 10.3109/21691401.2015.100851010.3109/21691401.2015.1008510 ↗
4. 10.1038/nrd169110.1038/nrd1691 ↗
5. 10.1021/cr980421n10.1021/cr980421n ↗
6. 10.1002/chem.20120315910.1002/chem.201203159 ↗
7. 10.1021/jm300580y10.1021/jm300580y ↗
8. 10.1021/nn500152u10.1021/nn500152u ↗
9. 10.1021/nn301148e10.1021/nn301148e ↗
10. 10.1016/j.biomaterials.2011.06.07210.1016/j.biomaterials.2011.06.072 ↗
11. 10.1158/0008-5472.CAN-12-456110.1158/0008-5472.CAN-12-4561 ↗
12. 10.1021/nn305011p10.1021/nn305011p ↗
13. 10.1016/j.biomaterials.2013.01.01010.1016/j.biomaterials.2013.01.010 ↗
14. 10.1016/j.biomaterials.2013.12.01810.1016/j.biomaterials.2013.12.018 ↗
15. 10.1080/21691401.2018.150803010.1080/21691401.2018.1508030 ↗
16. 10.1016/j.biomaterials.2011.07.07110.1016/j.biomaterials.2011.07.071 ↗
17. 10.1080/21691401.2017.142007210.1080/21691401.2017.1420072 ↗
18. 10.1080/21691401.2018.145026510.1080/21691401.2018.1450265 ↗
19. 10.1002/adma.20130189010.1002/adma.201301890 ↗
20. 10.1016/j.biomaterials.2015.01.07410.1016/j.biomaterials.2015.01.074 ↗
21. 10.1002/adma.20120468310.1002/adma.201204683 ↗
22. 10.1080/21691401.2017.138438410.1080/21691401.2017.1384384 ↗
23. 10.1021/cr400407a10.1021/cr400407a ↗
24. 10.1002/adma.20070197410.1002/adma.200701974 ↗
25. 10.1021/nn500722y10.1021/nn500722y ↗
26. 10.1021/am503583s10.1021/am503583s ↗
27. 10.1021/jp064341w10.1021/jp064341w ↗
28. 10.1021/bm100396s10.1021/bm100396s ↗
29. 10.1113/jphysiol.1973.sp01008610.1113/jphysiol.1973.sp010086 ↗
30. 10.1002/adma.20080122210.1002/adma.200801222 ↗
31. 10.1021/nn404117j10.1021/nn404117j ↗
32. 10.1016/j.jinorgbio.2004.05.01710.1016/j.jinorgbio.2004.05.017 ↗